Skip to main content

Table 1 Demographics

From: A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine

Characteristic

Total

(N = 167)

n (%)

Sex

 Male

31 (18.6)

 Female

136 (81.4)

Age (years)a

45.0 (19–64)

BMI (kg)b

28.7 (7.0)

Race

 American Indian or Alaska Native

0

 Asian

2 (1.2)

 Black or African American

25 (15.0)

 Native Hawaiian or Other Pacific Islander

1 (0.6)

 White

136 (81.4)

 Other

3 (1.8)

  1. BMI body mass index
  2. aMedian (range)
  3. bMean (SD)